
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
View Full LandscapeTarget Indication
Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
Clinical Trial
NCT00238446Last updated: 2/9/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Non-alcoholic Fatty Liver Disease (NAFLD)
Heart Transplantation
Influenza
Diabetic Retinopathy
Hypertension